Načítá se...
A bispecific EpCAM/CD133 targeted toxin is effective against carcinoma
The discovery of chemoresistant cancer stem cells (CSCs) in carcinomas has created the need for therapies that specifically target these subpopulations of cells. Here we characterized a bispecific targeted toxin that is composed of two antibody fragments and a catalytic protein toxin allowing it to...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3994189/ https://ncbi.nlm.nih.gov/pubmed/23900680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-013-0290-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|